Symbol Lookup from Yahoo Finance

Trending Tickers

Symbol	Name	Last Price	Change	Change %
ETH-USD	Ethereum USD	3,585.80	+204.47	+6.05%
SYM	Symbotic Inc.	24.00	-13.41	-35.86%
UMAC	Unusual Machines, Inc.	9.89	+4.53	+84.51%
SOFI	SoFi Technologies, Inc.	16.12	+0.63	+4.07%
VCIG	VCI Global Limited	4.1000	+2.2800	+125.27%
ACHR	Archer Aviation Inc.	8.08	+0.86	+11.91%
DOGE-USD	Dogecoin USD	0.41	+0.02	+5.11%
HUT	Hut 8 Corp.	28.45	+4.03	+16.50%
ETH-CAD	Ethereum CAD	5,028.78	+286.75	+6.05%
SHIB-USD	Shiba Inu USD	0.00	+0.00	+4.96%
APLT	Applied Therapeutics, Inc.	8.57	-1.64	-16.06%
SOS	SOS Limited	9.93	+2.98	+42.88%
PONY	Pony AI Inc. American Depositary Shares	12.00	-1.00	-7.69%
HUT.TO	HUT 8 CORP	39.87	+5.60	+16.34%
DOGE-CAD	Dogecoin CAD	0.57	+0.03	+5.11%
UAN	CVR Partners, LP	75.77	+5.50	+7.83%
SHIB-CAD	Shiba Inu CAD	0.00	+0.00	+4.96%
PEPE24478-USD	Pepe USD	0.00	+0.00	+7.76%
OTLK	Outlook Therapeutics, Inc.	1.7000	-3.1900	-65.24%
XRP-USD	XRP USD	1.47	+0.09	+6.81%
ADA-USD	Cardano USD	1.01	+0.05	+5.01%
ACN	Accenture plc	362.16	-1.02	-0.28%
ETHU	Volatility Shares Trust 2x Ethe	10.05	+1.59	+18.79%
BONK-USD	Bonk USD	0.00	+0.00	+5.13%
AMC	AMC Entertainment Holdings, Inc	4.9700	+0.1700	+3.54%

Related News

Symbotic delays 10-K filing while cutting Q1 outlook

Warehouse robotics and automation innovator Symbotic (SYM) has delayed filing its 10-K report to the Securities and Exchange Commission (SEC), the company cutting its outlook on a financial error around its revenue it is trying to correct. Julie Hyman and Josh Lipton report more on the story. To watch more expert insights and analysis on the latest market action, check out more Market Domination here. This post was written by Luke Carberry Mogan.

Yahoo Finance Video 6 hours ago

SYM
Symbotic, Nutanix, Dell Technologies: Top Stocks

Symbotic Inc. (SYM) stock is plunging by 40% at the time of this video's posting after delaying its 10K report to the Securities and Exchange Commission (SEC), the robotics company stating it is trying to assess the impact of a revenue error. Cloud computing company Nutanix (NTNX) beat first quarter earnings estimates while reaffirming its full-year revenue guidance. Dell Technologies (DELL) shares continue to sink following a revenue miss. To watch more expert insights and analysis on the latest market action, check out more Wealth here. This post was written by Luke Carberry Mogan.

Yahoo Finance Video 11 hours ago

DELL

NTNX
Unusual Machines CEO: Donald Trump Jr. Advisory Role Isn’t About Political Connections

Drone-parts maker Unusual Machines says Donald Trump Jr.’s advisory role is about the president-elect’s son’s business network, not his political connections. News of Trump Jr. being named an advisor to the Orlando, Fla., company sent shares surging Wednesday. “I would never ask him to do anything or facilitate anything like that,” Chief Executive Allan Evans said, about whether Trump Jr.’s connections would be helpful in securing certain government approvals.

The Wall Street Journal 5 hours ago

UMAC
Carl Icahn Is Buying Up Stock in This Fertilizer Producer. It’s All About Trump 2.0.

Carl Icahn is adding to a position in fertilizer producer CVR Partners. Falling costs would be one good reason to do that.

Barrons.com 6 hours ago

UAN
Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia

NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a biopharmaceutical company dedicated to creating transformative treatments for rare disease, today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the New Drug Application (NDA) for govorestat, a novel, central nervous system (CNS)-penetrant aldose reductase inhibitor (ARI), for the treatment of Classic Galactosemia. The CRL indicates that the FDA com

GlobeNewswire 7 hours ago

APLT
Symbotic Stock Sinks Nearly 40% On Filing Delay, Lowered Outlook

Symbotic stock sank nearly 40% Wednesday after the robotics company announced it needed more time to file its annual report.

Investor's Business Daily 7 hours ago

SYM
Symbotic Inc. (SYM): Downgraded by KeyBanc Amid Accounting Error Concerns

We recently compiled a list of the 15 AI News You Should Not Ignore. In this article, we are going to take a look at where Symbotic Inc. (NASDAQ:SYM) stands against the other AI stocks. Even as the United States pursues a tougher trade policy towards China, the latest indication being the tightening of export restrictions […]

Insider Monkey 8 hours ago

SYM
Symbotic Stock Is Plunging on Earnings Restatement, Lowered Outlook

Robotics company Symbotic discovers a significant error ‘related to system revenue recognition.’ The annual report will be in late.

Barrons.com 8 hours ago

SYM
Top Midday Decliners

Symbotic (SYM) said it submitted a notification of late filing for its annual report for the fiscal

PREMIUM
MT Newswires 9 hours ago

GRFS

SYM
Walmart-Backed Symbotic Stock Plunges on Accounting Errors

Symbotic, the AI-driven warehouse technology company backed by Walmart, warned about accounting errors, sending its shares plunging.

Investopedia 9 hours ago

SYM

WMT
Pony.ai Lists on Nasdaq

NEW YORK, November 27, 2024--NASDAQ MarketSite – Pony.ai, a global leader in autonomous driving technology, today listed on the Nasdaq Global Select Market (NASDAQ: PONY) and celebrated its initial public offering by ringing the Nasdaq opening bell. The IPO marks a significant milestone in Pony.ai’s journey toward global leadership in the large-scale commercialization and mass production of autonomous vehicles.

Business Wire 11 hours ago

PONY
Outlook Therapeutics stock craters as the wet AMD drug fails Phase III trial

The Norse Eight trial was part of the data requested by the FDA after the agency rejected the BLA for the company’s Lytenava last year.

Pharmaceutical Technology 12 hours ago

OTLK
Outlook Therapeutics stock craters as wet AMD drug fails Phase III trial

The Norse Eight trial was part of the data requested by the FDA after the agency rejected the BLA for the company’s Lytenava last year.

Clinical Trials Arena 12 hours ago

OTLK
Vitalik Buterin Donated $1M in Ether to Coin Center Hours After Tornado Cash Victory

Vitalik Buterin donated 30 ETH, worth just over $1 million, to Coin Center on Tuesday night.The donation came hours after a Coinbase-backed suit challenging U.S. sanctions against Tornado Cash won an appeals court victory.Coin Center is pursuing its own lawsuit against the Treasury Department's sanctions in a different appeals court.

CoinDesk 12 hours ago

ETH-USD
Symbotic's Accounting Errors Triggers 38% Stock Plunge

Revenue recognition blunder exposes internal control flaws, wiping billions off Symbotic's market value.

GuruFocus.com 12 hours ago

SYM
Walmart-backed Symbotic plummets 35% on delayed annual filing, financial reporting concerns

Symbotic said it needed more time to assess the financial impacts of correcting a revenue recognition error and its effects on the fiscal year ended September 28, 2024. The company, which went public in June 2022, builds and operates robotic warehouse systems for retail giants, including Walmart, Target, Albertsons, and C&S Wholesale. As of Jan. 2024, Walmart owned a 14.5% stake in Symbotic, according to LSEG data.

Reuters 13 hours ago

SYM

WMT
Softbank-Backed Symbotic Sinks as Accounting Errors Hit Outlook

(Bloomberg) -- Symbotic Inc. shares tumbled as much as 39% on Wednesday after the warehouse automation company cut its first-quarter revenue forecast and said it was unable to file its annual filing due to accounting errors. Most Read from BloombergNew York City’s ‘Living Breakwaters’ Brace for Stormier SeasIn Italy’s Motor City, Car-Free Options Are GrowingIn Traffic-Weary Toronto, a Battle Breaks Out Over Bike LanesIn Kansas City, a First-Ever Stadium Designed for Women’s Sports Takes the Fiel

Bloomberg 13 hours ago

SYM

SFTBY
Why Is Eye Disease-Focused Outlook Therapeutics Stock Trading Lower On Wednesday?

Outlook Therapeutics Inc. (NASDAQ:OTLK) revealed preliminary topline results of NORSE EIGHT, the second of two clinical trials evaluating ONS-5010 in wet AMD patients. In the NORSE EIGHT trial, ONS-5010 did not meet the pre-specified noninferiority endpoint at week 8 set forth in the special protocol assessment (SPA) with the FDA. The pre-specified noninferiority endpoint was measured by mean change in best corrected visual acuity (BCVA) from baseline to week 8. Also Read: Why Is Eye Disease-Foc

Benzinga 13 hours ago

OTLK

ROG.SW
Sector Update: Health Care Stocks Rise Pre-Bell Wednesday

Health care stocks rose premarket Wednesday as the Health Care Select Sector SPDR Fund (XLV) advance

PREMIUM
MT Newswires 14 hours ago

GRFS

OTLK
Robotics Company Symbotic Stock Plummets Over 30% After Delayed Filing And Revenue Errors - What's Going On?

On Wednesday, Symbotic Inc (NASDAQ:SYM) announced a delay in filing its Annual Report on Form 10-K for the fiscal year ending September 28, 2024. The company cited the need for additional time to evaluate revenue recognition errors’ financial impacts and address related internal control weaknesses. The stock is down 31% in premarket trade. Also Read: Apple Faces Modest Growth As IDC Forecasts Smartphone Market Rebound These issues were initially identified in Symbotic’s recent earnings release.

Benzinga 14 hours ago

SYM

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Trending Tickers

Related News

Symbotic delays 10-K filing while cutting Q1 outlook

Symbotic, Nutanix, Dell Technologies: Top Stocks

Unusual Machines CEO: Donald Trump Jr. Advisory Role Isn’t About Political Connections

Carl Icahn Is Buying Up Stock in This Fertilizer Producer. It’s All About Trump 2.0.

Applied Therapeutics Receives Complete Response Letter from U.S. FDA Regarding New Drug Application for Govorestat for Classic Galactosemia

Symbotic Stock Sinks Nearly 40% On Filing Delay, Lowered Outlook

Symbotic Inc. (SYM): Downgraded by KeyBanc Amid Accounting Error Concerns

Symbotic Stock Is Plunging on Earnings Restatement, Lowered Outlook

Top Midday Decliners

Walmart-Backed Symbotic Stock Plunges on Accounting Errors

Pony.ai Lists on Nasdaq

Outlook Therapeutics stock craters as the wet AMD drug fails Phase III trial

Outlook Therapeutics stock craters as wet AMD drug fails Phase III trial

Vitalik Buterin Donated $1M in Ether to Coin Center Hours After Tornado Cash Victory

Symbotic's Accounting Errors Triggers 38% Stock Plunge

Walmart-backed Symbotic plummets 35% on delayed annual filing, financial reporting concerns

Softbank-Backed Symbotic Sinks as Accounting Errors Hit Outlook

Why Is Eye Disease-Focused Outlook Therapeutics Stock Trading Lower On Wednesday?

Sector Update: Health Care Stocks Rise Pre-Bell Wednesday

Robotics Company Symbotic Stock Plummets Over 30% After Delayed Filing And Revenue Errors - What's Going On?